HIV Prevention & Treatment

Emtricitabine/Tenofovir

Daily antiretroviral therapy for HIV treatment and pre-exposure prophylaxis (PrEP).

Emtricitabine/Tenofovir is a prescription combination medication used both for the treatment of HIV-1 infection and as pre-exposure prophylaxis (PrEP) to prevent HIV acquisition. As two nucleoside reverse transcriptase inhibitors (NRTIs), emtricitabine and tenofovir work together to block HIV replication and reduce viral load. When taken daily as PrEP, it lowers the risk of HIV transmission by over 90% for sexual exposure and over 70% for injection drug use exposure.

Ingredients dosages:

Frequency:

Quantity:

Not sure about dosages? Don't worry, your provider will adjust or confirm your selection after checkout.

Total

$0.00

Here's what happens next:

  1. 1

    Product checkout

    We'll direct you to our product detail page where you can start the checkout process. You'll be charged for the medical consultation but the medication charge is a hold until the official provider review.

  2. 2

    Comprehensive Medical Questionnaire

    After purchase, you'll be directed to a medical assessment covering your medical history, current medications, and specific symptoms.

  3. 3

    Licensed Provider Review

    A licensed healthcare provider reviews your complete medical profile, ensuring this treatment is safe and appropriate for you.

  4. 4

    Personalized Treatment Plan

    Your provider may recommend an adjustment to your prescription based on your full medical profile before approving your treatment.

HIPAA Compliant
Certified Providers

  • Reduces HIV-1 viral load to undetectable levels in treatment regimens

  • When used as PrEP, lowers risk of HIV infection by up to 92% with daily adherence

  • Supports immune system preservation and long-term health outcomes

  • Improves treatment adherence with a single daily tablet combination

  • Well-studied and recommended as first-line therapy for both prevention and management of HIV

  • Emtricitabine: NRTI that inhibits reverse transcriptase, preventing viral replication.

  • Tenofovir disoproxil fumarate: NRTI that blocks reverse transcriptase enzyme, enhancing antiviral efficacy when combined with emtricitabine

  • Take one tablet by mouth once daily, with or without food

  • For PrEP, HIV-negative status must be confirmed before initiation and re-tested regularly

  • For HIV treatment, adherence to daily dosing is essential to maintain viral suppression

  • Do not miss doses to prevent loss of effectiveness and resistance development